KINGSTON, Feb. 10 /CNW Telbec/ - Millenium Biologix Corporation (TSX: MBC) (“Millenium” or “the Company”), a leading biomedical company developing minimally invasive medical devices and skeletal tissue regeneration products for targeted orthopedic uses, today released its unaudited consolidated financial statements for the three and twelve-months ended December 31, 2004.
